What are the key points to take into consideration design a clinical trial?

ESGO eAcademy, Nicole Concin, 376725

Latest date in gyn tumours - Unansweared questions: Cervical Cancer

ESGO eAcademy, Mansoor Raza Mirza, 376724

Latest date in gyn tumours - Unansweared questions: Endometrial cancer

ESGO eAcademy, Ana Oaknin, 376723

Latest date in gyn tumour - Unansweared questions: Ovarian Cancer

ESGO eAcademy, Isabelle Ray-Coquard, 376722

What is the role of a cooperative study group in ENGOT trials

ESGO eAcademy, Andreas du Bois, 376721

What is ENGOT

ESGO eAcademy, Mansoor Raza Mirza, 376720

Objectives of the meeting

ESGO eAcademy, Domenica Lorusso, 376719

Ovarian Cancer - Setting a new standard of care!

ESGO eAcademy, Mansoor Raza Mirza, 376616

Treatment of advanced and recurrent endometrial cancer

ESGO eAcademy, Domenica Lorusso, 376615

Surgical advances and perioperative management of ovarian cancer

ESGO eAcademy, Christina Fotopoulou, 376614

Meet the surgeon: Surgical anatomy of pelvic exenteration by Santiago Domingo

ESGO eAcademy, Faculty / Presenter(s), 376589

How to address the patients sexual health in the settings of Gynecologic malignancy?

ESGO eAcademy, Kathrin Kirchheiner, 376220

Operative management of locally advanced recurrent vulva tumor

ESGO eAcademy, Balazs Molnar, 376192

Tumour Board 11: Management of patients with ovarian cancer

ESGO eAcademy, Faculty / Presenters, 375430

Tumour Board 10: Therapeutic options for the treatment of primary advanced and recurrent endometrial cancer

ESGO eAcademy, Faculty / Presenters, 375429

Surgery vs Neoadjuvant Chemotherapy: Anticipation of the TRUST Trial

ESGO eAcademy, Christina Fotopoulou, 375367

Optimal Peri-Operative Management

ESGO eAcademy, Stephanie Schneider, 375364

Update Systemic Therapy in Gynecologic Sarcoma

ESGO eAcademy, Patricia Pautier, 375363

Role of Surgery in Gynecologic Sarcoma

ESGO eAcademy, Philippe Morice, 375362

Therapy in Advanced and Metastatic Endometrial Cancer 2022

ESGO eAcademy, Christian Marth, 375361

Managing Intraoperative Bleeding at the Time of Surgical Debulking

ESGO eAcademy, Luis Chiva, 375360

Conservative Management of Anastomotic Leakage

ESGO eAcademy, Piero Alesina, 375359

How to Select Patients for Either PDS or NACT

ESGO eAcademy, Dennis Chi, 375358

Technique of Radical Trachelectomy

ESGO eAcademy, Alexandros Rodolakis, 375357

Surgical Management Stage IV Ovarian Cancer

ESGO eAcademy, Christina Fotopoulou, 375356

Lymphadenectomy in Ovarian Cancer Surgery

ESGO eAcademy, Beyhan Ataseven, 375355

Day 3 - November 25th, 2022 - Live Surgeries Transmission

ESGO eAcademy, Faculty / Presenters, 370133

Live Surgeries Transmission

ESGO eAcademy, Faculty / Presenters, 370141

Session 7: Anthropological Perspectives in Ovarian Cancers

ESGO eAcademy, Faculty / Presenters, 370140

Liver, Diaphragm and Gall Bladder Surgeries (Video)

ESGO eAcademy, Beyhan Ataseven, 373955

Modified posterior exenteration and Excision of the pouch of Douglas sparing the rectum

ESGO eAcademy, Enrique Chacon, 373954

Colon and Intestinal Mobilization and Resection, Total Peritonectomy/ TROMP_ Technique (Video)

ESGO eAcademy, Mustafa Zelal Muallem, 373953

Pelvic and Para-Aortic Lymphadenectomy (Video)

ESGO eAcademy, Ane Gerda Z Eriksson, 373951

Day 2 - November 24th, 2022 - Afternoon Sessions

ESGO eAcademy, Faculty / Presenters, 370132

Primary Debulking Surgery (VIdeo)

ESGO eAcademy, Philipp Harter, 373946

Session 6: Video Session of Ovarian Cancers

ESGO eAcademy, Faculty / Presenters, 370139

Session 5: Management of Complications

ESGO eAcademy, Faculty / Presenters, 370138

Day 2 - November 24th, 2022 - Morning Sessions

ESGO eAcademy, Faculty / Presenters, 370131

Role of Robotic Surgery in EOC

ESGO eAcademy, Rainer Kimmig, 373922

Session 4: Great Debates in Ovarian Carcinoma

ESGO eAcademy, Faculty / Presenters, 370137

Day 1 - November 23rd, 2022 - Afternoon Sessions

ESGO eAcademy, Faculty / Presenters, 370130

Session 3: Debulking of the Upper Abdomen

ESGO eAcademy, Faculty / Presenters, 370136

Session 2: Dealing with pelvic disease, lower Abdomen and retroperitoneum

ESGO eAcademy, Faculty / Presenters, 370135

Session 1: Introduction

ESGO eAcademy, Faculty / Presenters, 370134

Day 1 - November 23rd, 2022 - Morning Sessions

ESGO eAcademy, Faculty / Presenters, 370129

Programme

ESGO eAcademy, Faculty / Presenters, 373985

Roundtable on HPV - questions & answers from experts

ESGO eAcademy, Faculty / Presenters, 374765

Live Surgical Anatomy of the Right Upper Quadrant after Cytoreductive Surgery

ESGO eAcademy, Ghanim Khatib, 374734

Summary of the ESGO 2022

ESGO eAcademy, Faculty / Presenters, 373806

Invitation to ESGO 2023 in Istanbul

ESGO eAcademy, Ali Ayhan, 373807

Tumours of low malignant potential - Algorithms presentation

ESGO eAcademy, Enora Laas, 373805

Vulvar and vaginal non-squamous carcinoma: Case-based presentation of the mobile app

ESGO eAcademy, Richard Schwameis, 373803

Conclusion

ESGO eAcademy, Isabelle Ray-Coquard, 373800

Pro: IP chemotherapy and HIPEC are essential tools in the toolbox for treating patients with ovarian carcinoma

ESGO eAcademy, Cagatay Taskiran, 373798

Vulvar and vaginal non-squamous carcinoma - Algorithms presentation

ESGO eAcademy, Mustafa Zelal Muallem, 373804

Tumours of low malignant potential: Case-based presentation of the mobile app

ESGO eAcademy, Enora Laas, 373802

Role of HIPEC and IP in ovarian cancer: Discussion

ESGO eAcademy, Willemien Van Driel, 373799

OUTCOMES OF GYNAECOLOGICAL CANCER SURGERY DURING THE COVID-19 PANDEMIC: RESULTS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE COVIDSURG-GYNAECOLOGICAL CANCER STUDY.

ESGO eAcademy, Leung Elaine, 373789

This side believes that definitive radio-chemotherapy is the treatment of choice in locally advanced cervical cancer

ESGO eAcademy, Remi Nout, 373796

Pros and cons of neoadjuvant chemotherapy and radical surgery versus definitive radio-chemotherapy in locally advanced cervical cancer

ESGO eAcademy, Jacob Lindegaard, 373794

Development of adjuvant treatment decision support tool for endometrial cancer patients by pooled analysis of data from 2000 women included in the PORTEC-1-3 trials and a prospective cohort study

ESGO eAcademy, Lisa Vermij, 373793

The ENSURE trial for women with early-stage endometrial cancer: A randomized controlled trial comparing the effect of a reduced versus usual follow-up schedule on patient satisfaction, health care use, and disease perceptions

ESGO eAcademy, Nicole Ezendam, 373790

ERAS pathway for gynecological oncology - a pre-post implementation cohort with 1211 patients.

ESGO eAcademy, Vanessa Samouelian, 373791

Secondary cytoreductive surgery in recurrent ovarian cancer: Summary of the current trial data (2022)

ESGO eAcademy, Stefano Greggi, 373782

Do the newly available therapies mitigate the role of surgery in this setting?

ESGO eAcademy, Robert L Coleman, 373783

Updates on radiotherapy in vulvar cancer

ESGO eAcademy, Alina Sturdza, 373786

Updates on surgical management

ESGO eAcademy, Maaike Oonk, 373787

Importance of selection criteria: “right patient, right setting”

ESGO eAcademy, Andreas du Bois, 373784

Update on palliative and supportive care in vulvar cancer

ESGO eAcademy, Alexandra Taylor, 373785

Radiotherapy: overview radiotherapy aspects, management of locally advanced, follow-up

ESGO eAcademy, Remi Nout, 373781

Why we need to test for HRD

ESGO eAcademy, Antonio Gonzalez Martin, 373776

New HRD tests on the horizon

ESGO eAcademy, Toon Van Gorp, 373778

Special aspects regarding vaginal cancer in childhood and adolescence

ESGO eAcademy, Gabriele Calaminus, 373779

Can we detect PARP resistance?

ESGO eAcademy, Anil Sood, 373777

Surgical aspects: diagnosis, management of early stage, reconstructive techniques

ESGO eAcademy, Christina Fotopoulou, 373780

HPV DNA vs. mRNA An Update on HPV Screenings

ESGO eAcademy, Marc Arbyn, 373770

Oncological and obstetrical outcomes of different fertility-sparing approaches

ESGO eAcademy, Philippe Morice, 373773

HPV Vaccines: Current State of the Art and Future Prospects

ESGO eAcademy, Murat Gultekin, 373771

Self-Sampling

ESGO eAcademy, Andreas M. Kaufmann, 373772

What are the definitive contra-indications for fertility-sparing management

ESGO eAcademy, Denis Querleu, 373774

Case discussion: the limits of fertility sparing

ESGO eAcademy, Luis Chiva, 373775

Oral poster session 4 : ID 605 - 1551 - 1311

ESGO eAcademy, Faculty / Presenters, 373760

Oral poster session 4 : ID 1492 - 903 - 972

ESGO eAcademy, Faculty / Presenters, 373759

What‘s new in perioperative care—prehabilitation

ESGO eAcademy, David Cibula, 373769

The scientific work behind perioperative protocols—how to study and publish multidisciplinary oriented care

ESGO eAcademy, Stephanie Schneider, 373767

The implementation of ERAS and ESGO perioperative protocols to everyday practise—why and how to do it

ESGO eAcademy, Maja Pakiz, 373768

Oral poster session 4 : ID 276 - 1657 - 1432

ESGO eAcademy, Faculty / Presenters, 373761

Imaging in cervical cancer

ESGO eAcademy, Faculty / Presenters, 374703

Imaging in endometrial cancer

ESGO eAcademy, Faculty / Presenters, 373744

Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohorT

ESGO eAcademy, Enrique Chacon, 373748

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

ESGO eAcademy, Willemijn van der Kolk, 373750

Fertility-sparing treatment in patients with IB1 cervical cancer - results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03)

ESGO eAcademy, Jiri Slama, 373752

The importance of pathological ultrastaging for sentinel lymph node biopsy in cervical cancer, the final outcome of the Sentix study (CEEGOG-CX01; ENGOT-CX2; NCT02494063)

ESGO eAcademy, Roman Kocian, 373749

Imaging in ovarian cancer

ESGO eAcademy, Ingfrid Haldorsen, 373747

Imaging in vulvar cancer

ESGO eAcademy, Faculty / Presenters, 373746

Paradigm shift in recurrent/ metastatic cervical cancer? What to expect and what to look for? Live Q&A

ESGO eAcademy, Faculty / Presenters, 374815

Conversations and Controversies in First-line Maintenance Therapy for Advanced Ovarian Cancer: Summary of the session

ESGO eAcademy, Philipp Harter, 374431

Transforming the future of advanced ovarian cancer care: What can we look forward to in 2023 and beyond?

ESGO eAcademy, Antonio Gonzalez Martin, 374430

Addressing unmet needs: How can we overcome current treatment challenges and improve outcomes in advanced ovarian cancer?

ESGO eAcademy, Toon Van Gorp, 374429

New approaches at the horizon for 2L+ treatment of r/m CC

ESGO eAcademy, Faculty / Presenters, 373738